Get the Stockscreener App
8.89
0.79%
0.07
Quantum Biopharma Ltd stock is traded at $8.89, with a volume of 44,683.
It is up +0.79% in the last 24 hours and up +40.89% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$8.82
Open:
$8.8
24h Volume:
44,683
Relative Volume:
0.30
Market Cap:
$34.09M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.22%
1M Performance:
+40.89%
6M Performance:
-41.09%
1Y Performance:
+413.87%
1-Day Range:
$8.45
$8.9999
1-Week Range:
$7.5201
$9.68
52-Week Range:
$1.35
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
8.89 | 33.82M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.20 | 113.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.96 | 78.69B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.23 | 52.32B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.99 | 52.15B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.84 | 35.52B | 447.02M | -1.18B | -906.14M | -6.1812 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Will Quantum BioPharma Ltd. stock attract ESG investorsGap Up & Reliable Volume Spike Alerts - ulpravda.ru
Quantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks - TipRanks
World Renowned Law Firm Grant & Eisenhofer Files Class - GlobeNewswire
VIX Spike: How Quantum BioPharma Ltd. stock reacts to global recession fearsMarket Activity Summary & Free Long-Term Investment Growth Plans - ulpravda.ru
Is Quantum BioPharma Ltd. (0K91) stock dividend growth reliableMarket Risk Report & High Accuracy Trade Alerts - ulpravda.ru
Can Quantum BioPharma Ltd. stock sustain market leadership2025 Earnings Impact & Capital Efficient Trade Techniques - DonanımHaber
Why Quantum BioPharma Ltd. stock is a must watch in 2025July 2025 Volume & Consistent Profit Trade Alerts - DonanımHaber
Quantum BioPharma (STU:0K91) EV-to-OCF : -3.48 (As of Dec. 18, 2025) - GuruFocus
Quantum BioPharma (STU:0K91) EV-to-FCF : -3.46 (As of Dec. 17, 2025) - GuruFocus
Published on: 2025-12-17 09:15:23 - moha.gov.vn
Cannabis Stocks To Follow TodayDecember 11th - MarketBeat
Quantum BioPharma’s Lawsuit Highlighted in CTV’s W5 Series - MSN
Cannabis Stocks To Follow NowDecember 1st - MarketBeat
Quantum BioPharma Closes Private Placement, Enhances Governance - TipRanks
Quantum BioPharma ends market offering agreement - MSN
Quantum BioPharma closes non-brokered private placement for $750 - Investing.com
Quantum BioPharma closes non-brokered private placement for $750 By Investing.com - Investing.com South Africa
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update - Yahoo Finance
Quantum BioPharma Highlights Growth at ArcStone-Kingswood Summit - MSN
Quantum BioPharma Ends Market Offering Agreement - TipRanks
How Quantum BioPharma Ltd. (0K91) stock correlates with oil marketsMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Can Quantum BioPharma Ltd. (0K91) stock resist broad market declines2025 Year in Review & Daily Stock Trend Reports - Newser
Is Quantum BioPharma Ltd. stock supported by strong cash flowsMarket Growth Summary & Community Consensus Trade Signals - Newser
Is Quantum BioPharma Ltd. (0K91) stock good for wealth creationJuly 2025 Action & Risk Managed Trade Strategies - Newser
Will Quantum BioPharma Ltd. (0K91) stock test record highs in 2025 - Newser
Quantum BioPharma Ltd. (QNTM) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Quantum BioPharma (QNTM) Stock Analysis Report | Financials & Insights - Benzinga
Quantum Biopharma Ltd. R (0K91.DU) stock price, news, quote and history - Yahoo Finance UK
Is Quantum BioPharma Ltd. (0K91) stock resilient in recession scenariosQuarterly Trade Report & Risk Adjusted Buy/Sell Alerts - Newser
Top Cannabis Stocks Worth WatchingNovember 29th - MarketBeat
Will Quantum BioPharma Ltd. (0K91) stock recover faster than industryWeekly Stock Summary & Accurate Buy Signal Alerts - Newser
Quantum BioPharma Lawsuit Alleging Market Manipulation Featured in CTV W5 Investigation - citybuzz
Quantum BioPharma’s Market Manipulation Allegations Featured in CTV W5 Investigation - citybuzz
Quantum Biopharma (QNTM) Alleges Stock Market Manipulation in W5 Series - GuruFocus
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC - marketscreener.com
Investigative News Program W5 Airs Final Segment on USD - GlobeNewswire
Quantum BioPharma Alleges Stock Manipulation in $700M Lawsuit - MSN
Cannabis Stocks To ResearchNovember 28th - MarketBeat
REPEAT: Award-winning Investigative News Program W5 Airs - GlobeNewswire
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC - The Manila Times
Quantum Biopharma's $700 Mln Market Manipulation Case Featured In CTV W5 Investigative Series - Nasdaq
Award-winning Investigative News Program W5 Airs Part 2 of - GlobeNewswire
How Quantum BioPharma Ltd. stock reacts to global recession fearsJuly 2025 Levels & Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Top Cannabis Stocks To ConsiderNovember 27th - MarketBeat
BioVaxys Announces Extension of Life Offering Closing Date - Investing News Network
‘Market manipulation’ cases trending up in Canada: regulator data - CTV News
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):